JMP Securities Reiterates Market Outperform Rating for Cidara Therapeutics (NASDAQ:CDTX)
JMP Securities reiterated their market outperform rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Tuesday,Benzinga reports. JMP Securities currently has a $46.00 price target on the biotechnology company’s stock. Several other brokerages have also commented on CDTX. Citigroup started coverage on shares of Cidara Therapeutics in a research […]
JMP Securities reiterated their market outperform rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Tuesday,Benzinga reports. JMP Securities currently has a $46.00 price target on the biotechnology company’s stock. Several other brokerages have also commented on CDTX. Citigroup started coverage on shares of Cidara Therapeutics in a research […]
